has been cited by the following article(s):
|
[1]
|
SPC25 promotes hepatocellular carcinoma metastasis via activating the FAK/PI3K/AKT signaling pathway through ITGB4
|
|
Oncology Reports,
2022 |
|
|
|
|
[2]
|
Epigenetic Enabled Normal Human Cells, Lead to First Cell's Unique Division System, Driving Tumorigenesis Evolution
|
|
Journal of Cancer Therapy,
2022 |
|
|
|
|
[3]
|
A Traceable Cancer Model: DNA Damage, Fragile Site-SMGs, Mitotic Slippage, 4n-Genome-Reduction to Fitness-Gained, Initiating, 2n First Cells
|
|
2021 |
|
|
|
|
[4]
|
Near-Dead Cells to Special Tetraploidy to First Cells to Cancer Diagnostic Morphology: Unlikely Therapy-Gain from For-Profit Industrial Goliath
|
|
2020 |
|
|
|
|
[5]
|
Genomic Instability in Cancer II: 4N-Skewed (90°) Reductive Division via Fragile Sites to Fitness Increase for Solid and Hematological Cancer Beginnings
|
|
2019 |
|
|
|
|
[6]
|
Genomic Instability in Cancer II: 4N-Skewed (90) Reductive Division via Fragile Sites to Fitness Increase for Solid and Hematological Cancer Beginnings
|
|
Journal of Cancer Therapy,
2019 |
|
|
|
|
[1]
|
SPC25 promotes hepatocellular carcinoma metastasis via activating the FAK/PI3K/AKT signaling pathway through ITGB4
Oncology Reports,
2022
DOI:10.3892/or.2022.8302
|
|
|
|